Kristin King is Head of Group Management, Boston Harbor Angels, and an active angel investor, www.bostonharborangels.com. Based in greater New York City Kristin actively champions biotech innovation across the startup ecosystem as mentor for NYU Endless Frontiers Lab, EIR for Yale Ventures, on the Board of Directors for Boston ENET, and board advisor for multiple startups. (https://endlessfrontierlabs.com/, https://ventures.yale.edu/, https://bostonenet.org/)
Kristin has over 25 years’ leadership roles in business development, M&A, corporate strategy, venture investment, commercial and technical roles. Starting her career designing stents, a patent inventor for Johnson & Johnson’s drug eluting stent, and progressing through leadership roles she has championed healthcare innovation within both startups and Fortune 100 Global companies including Nihon Kohden, Ansell Healthcare, Becton Dickinson, Johnson & Johnson Cordis, Abbott Vascular, and Pfizer. Kristin holds an MBA in Finance and Marketing from NYU Stern and a BS in bioengineering and mathematics from Syracuse.